Keizo Anzai
Impact in
- Hepatology top 2%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 43
- Liver Disease Diagnosis and Treatment 35
- Hepatitis B Virus Studies 7
- Surgery 19
- Pancreatic function and diabetes 7
- Co-authors
- Hirokazu Takahashi (27 shared papers)Yuichiro Eguchi (43 shared papers)Takumi Kawaguchi (8 shared papers)Yoichiro Kitajima (12 shared papers)Iwata Ozaki (20 shared papers)Dan Nakano (4 shared papers)Takuji Torimura (5 shared papers)Shinobu Yoshinaga (4 shared papers)
- Journals
- Hepatology Research (10 papers)Journal of Gastroenterology (7 papers)Journal of Clinical Biochemistry and Nutrition (5 papers)Obesity Research & Clinical Practice (4 papers)Digestion (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Keizo Anzai
112 papers receiving 2.7k citations
Keizo Anzai's Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 361
- Epidemiology 1.2k
- Endocrinology, Diabetes and Metabolism 449
- Periodontics 91
- Physiology 433
Countries citing papers authored by Keizo Anzai
This map shows the geographic impact of Keizo Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Anzai more than expected).
Fields of papers citing papers by Keizo Anzai
This network shows the impact of papers produced by Keizo Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Anzai. The network helps show where Keizo Anzai may publish in the future.
Co-authors
The 25 scholars most cited alongside Keizo Anzai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MAFLD identifies patients with significant hepatic fibrosis better than NAFLD Hit paper breakdown → | 2020 | 294 |
| 2 | 2014 | 159 | |
| 3 | 2017 | 126 | |
| 4 | 2013 | 122 | |
| 5 | 2021 | 116 | |
| 6 | 2013 | 109 | |
| 7 | 2017 | 109 | |
| 8 | 2007 | 94 | |
| 9 | 2015 | 80 | |
| 10 | 2001 | 75 | |
| 11 | 2019 | 61 | |
| 12 | 2020 | 55 | |
| 13 | 2014 | 52 | |
| 14 | 2014 | 43 | |
| 15 | 2019 | 43 | |
| 16 | 2018 | 42 | |
| 17 | 1991 | 41 | |
| 18 | 1998 | 39 | |
| 19 | 2011 | 39 | |
| 20 | 2020 | 37 |
About Keizo Anzai
Keizo Anzai is a scholar working on Epidemiology, Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 118 papers that have together received 2.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (35 papers), Diabetes and associated disorders (14 papers), Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers), Pancreatic function and diabetes (7 papers), Diet, Metabolism, and Disease (7 papers), Immune Cell Function and Interaction (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Hepatology (361 citations), Epidemiology (1.2k citations), Endocrinology, Diabetes and Metabolism (449 citations), Periodontics (91 citations) and Physiology (433 citations). Keizo Anzai has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hirokazu Takahashi, Yuichiro Eguchi, Takumi Kawaguchi, Yoichiro Kitajima, Iwata Ozaki, Dan Nakano, Takuji Torimura, Shinobu Yoshinaga, Sakura Yamamura and Tsubasa Tsutsumi. Their work appears in journals such as Hepatology Research, Journal of Gastroenterology, Journal of Clinical Biochemistry and Nutrition, Obesity Research & Clinical Practice and Digestion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.